Related Experiment Video
Updated: Oct 23, 2025

Mitigation of Blood Borne Cell Attachment to Metal Implants through CD47-Derived Peptide Immobilization
Published on: December 3, 2020
Antibody:CD47 ratio regulates macrophage phagocytosis through competitive receptor phosphorylation
Emily C Suter1, Eva M Schmid2, Andrew R Harris3
1Department of Bioengineering, University of California, Berkeley, Berkeley, CA, USA; UC Berkeley/UC San Francisco Graduate Group in Bioengineering, Berkeley, CA, USA.
Abstract:
Cancer immunotherapies often modulate macrophage effector function by introducing either targeting antibodies that activate Fcγ receptors (FcγRs) or blocking antibodies that disrupt inhibitory SIRPα-CD47 engagement. However, how these competing signals are integrated is poorly understood, raising questions about how to effectively titrate immune responses. Here, we find that macrophage phagocytic decisions are regulated by the ratio of activating ligand to inhibitory ligand over a broad range of absolute molecular densities. Using both endogenous and chimeric receptors, we show that activating:inhibitory ligand ratios of at least 10:1 are required to promote phagocytosis of model antibody-opsonized CD47-inhibited targets and that lowering that ratio reduces FcγR phosphorylation because of inhibitory phosphatases recruited to CD47-bound SIRPα. We demonstrate that ratiometric signaling is critical for phagocytosis of tumor cells and can be modified by blocking SIRPα, indicating that balancing targeting and blocking antibodies may be important for controlling macrophage phagocytosis in cancer immunotherapy.
Insights
Macrophage phagocytosis decisions in cancer immunotherapy depend on the ratio of activating to inhibitory signals, not just absolute levels. A 10:1 activating to inhibitory ligand ratio is crucial for effective tumor cell clearance.
Area of Science:
- Immunology
- Cancer Biology
- Cellular Signaling
Background:
- Cancer immunotherapies leverage macrophages by modulating Fcγ receptors (FcγRs) and SIRPα-CD47 interactions.
- The integration of competing activating and inhibitory signals in macrophages remains poorly understood.
- Effective titration of immune responses in immunotherapy requires understanding signal integration.
Purpose of the Study:
- To investigate how macrophages integrate competing activating (FcγR) and inhibitory (SIRPα-CD47) signals.
- To determine the critical ratio of activating to inhibitory ligands for macrophage phagocytosis.
- To explore the implications of ratiometric signaling for cancer immunotherapy.
Main Methods:
- Utilized endogenous and chimeric receptors to model macrophage activation.
- Quantified phagocytosis of antibody-opsonized targets with varying ligand densities.
- Assessed FcγR phosphorylation and phosphatase recruitment in response to ligand engagement.
Main Results:
- Macrophage phagocytic activity is governed by the ratio of activating to inhibitory ligands, not absolute densities.
- An activating to inhibitory ligand ratio of at least 10:1 is necessary for phagocytosis of CD47-inhibited targets.
- Lower ratios reduce FcγR phosphorylation due to inhibitory phosphatases recruited by SIRPα-CD47.
Conclusions:
- Ratiometric signaling is critical for macrophage-mediated phagocytosis of tumor cells.
- Modulating SIRPα signaling can alter phagocytic responses.
- Balancing targeting and blocking antibodies is essential for optimizing macrophage phagocytosis in cancer immunotherapy.
Related Concept Videos
Phagocytosis of Apoptotic Cells
Normal cells contain receptors that prevent them from being recognized...
Immune Surveillance by NK Cells and Phagocytes
Natural Killer Cells: The Fast Responders
NK cells are large granular lymphocytes found in the blood and lymphatic system. These...
Receptor Downregulation in MVBs
The EGFR can initiate signaling pathways that lead to cell proliferation, migration, and differentiation. Overexpression of EGFR stimulates cells to proliferate. Excessive EGFR...
Antibody Actions
Neutralization
Antibodies can bind to pathogens, preventing them from infecting host cells. This process...

